Skip to content

Efficacy trial of 4 weeks ingestion of the development code MSHF001 food

Efficacy trial of 4 weeks ingestion of the development code MSHF001 food - Efficacy trial of 4 weeks ingestion of the development code MSHF001 food

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038871
Enrollment
100
Registered
2019-12-13
Start date
2019-12-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

In healthy females aged 40 to 59 years with subjective symptoms of hot flash, daily ingestion of two MSHF001(development code) food tablets twice a day, after breakfast meals and at bed time for 4 wee

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: -Healthy females 1.Subjects at climacteric period who have the symptoms of hot flushes. 2.Subjects at climacteric period who have the symptoms of hot flushes. 3.Subjects between ages 20 and 35 who have stable menstrual cycle.

Exclusion criteria

Exclusion criteria: -Subjects with systemic illness. -Subjects who are diagnosed as menopausal disorders. -Subjects who are under Hormone Replacement Therapy, HRT, and/or medication which would affect blood hormone levels. -Subjects who are outpatients or were treated by doctor within a month. -Subjects who regularly take medicine. -Subjects who regularly take medicines that affect menopausal symptoms. -Subjects who are pregnant or lactating, or planned to become pregnant in the near future. -Subjects with smoking habit. -Subjects with drinking habit in 5 or more days a week. -Subjects who have possibilities for emerging allergy to foods, metals, and drugs. -Subjects with illnesses or diseases on their face, especially such as atopic dermatitis, or psoriasis, or severe acne. -Subjects who habitually having specific polyphenol-rich health food and drink. -Subjects with high anxiety questionnaire values. -Subjects with high Kupperman Kohnenki Shohgai Index. -Subjects who easily have skin rashes. -Subjects with potential conflict of interest.

Design outcomes

Primary

MeasureTime frame
Evaluation of 4 weeks ingestion of the development code MSHF001 food effects of on general malaise and so on.

Countries

Japan

Contacts

Public ContactMayumi Ohtsuka

Kao Corporation Biological Science Research

ohtsuka.mayumi@kao.com+81-285-68-7538

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026